Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome
Authors
Keywords
-
Journal
PSYCHOPHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-21
DOI
10.1007/s00213-018-5102-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-inflammatory properties of edible mushrooms: A review
- (2018) Bożena Muszyńska et al. FOOD CHEMISTRY
- Antibacterial activity of antipsychotic agents, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity
- (2018) Hassan Nehme et al. PLoS One
- Prebiotic attenuation of olanzapine-induced weight gain in rats: analysis of central and peripheral biomarkers and gut microbiota
- (2018) Amy Chia-Ching Kao et al. Translational Psychiatry
- Metabolic Syndrome and Cardiovascular Risk in People Treated with Long-Acting Injectable Antipsychotics
- (2018) Vanessa Sanchez-Martinez et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations
- (2018) Marcel van de Wouw et al. JOURNAL OF PHYSIOLOGY-LONDON
- Fecal microbiota and bile acid interactions with systemic and adipose tissue metabolism in diet-induced weight loss of obese postmenopausal women
- (2018) José O. Alemán et al. Journal of Translational Medicine
- Extensive impact of non-antibiotic drugs on human gut bacteria
- (2018) Lisa Maier et al. NATURE
- Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function
- (2018) Sofia Cussotto et al. PSYCHOPHARMACOLOGY
- Changes in metabolism and microbiota after 24-week risperidone treatment in drug naïve, normal weight patients with first episode schizophrenia
- (2018) Xiuxia Yuan et al. SCHIZOPHRENIA RESEARCH
- The microbiome-gut-brain axis: implications for schizophrenia and antipsychotic induced weight gain
- (2017) S. Kanji et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- International trends in antipsychotic use: A study in 16 countries, 2005–2014
- (2017) Óskar Hálfdánarson et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- LPS-Induced Low-Grade Inflammation Increases Hypothalamic JNK Expression and Causes Central Insulin Resistance Irrespective of Body Weight Changes
- (2017) Rodrigo Rorato et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Development of Metabolic Syndrome in Drug-Naive Adolescents After 12 Months of Second-Generation Antipsychotic Treatment
- (2017) Christina Power Sjo et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Loss of lipopolysaccharide-binding protein attenuates the development of diet-induced non-alcoholic fatty liver disease in mice
- (2017) Cheng Jun Jin et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Gut Microbiota-Dependent Modulation of Energy Metabolism
- (2017) Christina N. Heiss et al. Journal of Innate Immunity
- Mechanisms underlying metabolic disturbances associated with psychosis and antipsychotic drug treatment
- (2017) Gavin P Reynolds et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Interaction Between Atypical Antipsychotics and the Gut Microbiome in a Bipolar Disease Cohort
- (2017) Stephanie A. Flowers et al. PHARMACOTHERAPY
- Alterations in Gut Microbiota and Immunity by Dietary Fat
- (2017) Bo-Gie Yang et al. YONSEI MEDICAL JOURNAL
- The Relationship between Serum Zonulin Level and Clinical and Laboratory Parameters of Childhood Obesity
- (2017) Tuncay Küme et al. Journal of Clinical Research in Pediatric Endocrinology
- Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options
- (2017) A. A. Verhaegen et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- A multi-national comparison of antipsychotic drug use in children and adolescents, 2005–2012
- (2017) Luuk J. Kalverdijk et al. Child and Adolescent Psychiatry and Mental Health
- Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response
- (2017) Emanuel Schwarz et al. SCHIZOPHRENIA RESEARCH
- Intestinal Dysbiosis, Gut Hyperpermeability and Bacterial Translocation: Missing Links Between Depression, Obesity and Type 2 Diabetes
- (2016) Anastasiya Slyepchenko et al. CURRENT PHARMACEUTICAL DESIGN
- Predicting Weight Gain in Patients Treated With Clozapine
- (2016) Sue Lynn Lau et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Metabolic effects of eradicating breath methane using antibiotics in prediabetic subjects with obesity
- (2016) Ruchi Mathur et al. Obesity
- Extended neuroleptic administration modulates NMDA-R subunit immunoexpression in the rat neocortex and diencephalon
- (2016) Marek Krzystanek et al. Pharmacological Reports
- Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis
- (2016) Jian-Ping Zhang et al. SCHIZOPHRENIA BULLETIN
- Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis
- (2016) Davy Vancampfort et al. World Psychiatry
- Impact of the gut microbiota on inflammation, obesity, and metabolic disease
- (2016) Claire L. Boulangé et al. Genome Medicine
- Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics
- (2016) Britta Galling et al. JAMA Psychiatry
- Effects of long-term treatment with the neuroleptics haloperidol, clozapine and olanzapine on immunoexpression of NMDA receptor subunits NR1, NR2A and NR2B in the rat hippocampus
- (2015) Marek Krzystanek et al. Pharmacological Reports
- Differential effects of olanzapine and clozapine on plasma levels of adipocytokines and total ghrelin
- (2015) Mong-Liang Lu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
- (2015) L. Shamseer et al. BMJ-British Medical Journal
- Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
- (2015) L. Shamseer et al. BMJ-British Medical Journal
- Use of the second-generation antipsychotic, risperidone and secondary weight gain are associated with an altered gut microbiota in children
- (2015) S M Bahr et al. Translational Psychiatry
- Risperidone-induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure
- (2015) Sarah M. Bahr et al. EBioMedicine
- Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice
- (2015) Marc Schneeberger et al. Scientific Reports
- SYRCLE’s risk of bias tool for animal studies
- (2014) Carlijn R Hooijmans et al. BMC Medical Research Methodology
- Altering the Intestinal Microbiota during a Critical Developmental Window Has Lasting Metabolic Consequences
- (2014) Laura M. Cox et al. CELL
- Do antipsychotics increase diabetes risk in children and adolescents?
- (2014) Britta Galling et al. Expert Opinion On Drug Safety
- Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis
- (2014) Maarten Bak et al. PLoS One
- The Antipsychotic Olanzapine Interacts with the Gut Microbiome to Cause Weight Gain in Mouse
- (2014) Andrew P. Morgan et al. PLoS One
- Molecular pathophysiology of metabolic effects of antipsychotic medications
- (2014) Jacob S. Ballon et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration
- (2014) Jan P. Vandenbroucke et al. International Journal of Surgery
- Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease
- (2013) Maitreyi Raman et al. Clinical Gastroenterology and Hepatology
- The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism
- (2013) Gijs den Besten et al. JOURNAL OF LIPID RESEARCH
- Related actions of probiotics and antibiotics on gut microbiota and weight modification
- (2013) Emmanouil Angelakis et al. LANCET INFECTIOUS DISEASES
- Serotonin Receptor 2C and Insulin Secretion
- (2013) Qiang Zhang et al. PLoS One
- The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43
- (2013) Ikuo Kimura et al. Nature Communications
- Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat
- (2013) K J Davey et al. Translational Psychiatry
- The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner
- (2012) G Clarke et al. MOLECULAR PSYCHIATRY
- Functional interactions between the gut microbiota and host metabolism
- (2012) Valentina Tremaroli et al. NATURE
- Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
- (2012) Jorge Henao-Mejia et al. NATURE
- The interplay between the intestinal microbiota and the brain
- (2012) Stephen M. Collins et al. NATURE REVIEWS MICROBIOLOGY
- Regulation of Metabolism: A Cross Talk Between Gut Microbiota and Its Human Host
- (2012) Rémy Burcelin PHYSIOLOGY
- Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters
- (2012) Kieran J. Davey et al. PSYCHOPHARMACOLOGY
- Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation
- (2011) M. De Hert et al. BRITISH JOURNAL OF PSYCHIATRY
- Leptin and cancer: from cancer stem cells to metastasis
- (2011) J. Park et al. ENDOCRINE-RELATED CANCER
- Gut microbiome, obesity, and metabolic dysfunction
- (2011) Herbert Tilg et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting gut microbiota in obesity: effects of prebiotics and probiotics
- (2011) Nathalie M. Delzenne et al. Nature Reviews Endocrinology
- Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London
- (2011) Chin-Kuo Chang et al. PLoS One
- Management of antipsychotic-related weight gain
- (2010) Lawrence Maayan et al. Expert Review of Neurotherapeutics
- Association Between Composition of the Human Gastrointestinal Microbiome and Development of Fatty Liver With Choline Deficiency
- (2010) Melanie D. Spencer et al. GASTROENTEROLOGY
- Hematopoietic Cell-Specific Deletion of Toll-like Receptor 4 Ameliorates Hepatic and Adipose Tissue Insulin Resistance in High-Fat-Fed Mice
- (2009) Maziyar Saberi et al. Cell Metabolism
- Adiponectin and JNK: metabolic/inflammatory pathways affecting gastrointestinal carcinogenesis
- (2009) H. Tilg et al. GUT
- Microbiota and SCFA in Lean and Overweight Healthy Subjects
- (2009) Andreas Schwiertz et al. Obesity
- Insulin resistance and secretion in vivo: Effects of different antipsychotics in an animal model
- (2009) Araba F. Chintoh et al. SCHIZOPHRENIA RESEARCH
- Non-pharmacological management of antipsychotic-induced weight gain: Systematic review and meta-analysis of randomised controlled trials
- (2008) Mario Álvarez-Jiménez et al. BRITISH JOURNAL OF PSYCHIATRY
- A core gut microbiome in obese and lean twins
- (2008) Peter J. Turnbaugh et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now